Triglyceride lowering by chromium picolinate in type 2 diabetic people

Abstract

In some studies in diabetic people, chromium picolinate supplementation has lowered readings for both plasma triglycerides and blood sugar. In the present study, relatively low dose supplementation (200 µg chromium) did not lower blood sugar readings, but did lower triglyceride values in people with the following characteristics: type 2 diabetes, moderately elevated blood sugar, and not using insulin therapy. These results support the supposition that chromium picolinate can affect triglyceride concentrations independently of effects on carbohydrate metabolism.